Objective Urine is a promising biomarker source for clinical proteomics *** physiological differences are common in multi-center clinical *** this study,we investigate whether significant differences are present in th...
详细信息
Objective Urine is a promising biomarker source for clinical proteomics *** physiological differences are common in multi-center clinical *** this study,we investigate whether significant differences are present in the urinary proteomes of individuals from different regions in *** In this study,morning urine samples were collected from healthy urban residents in three regions of China(Haikou,Xi’an and Xining)and urinary proteins were preserved using a membrane-based method(Urimem).The urine proteomes of 27 normal samples were analyzed using LC-MS/MS and compared among three *** annotation of the differential proteins among the three areas was analyzed using the DAVID online database,and pathway enrichment of the differential urinary proteins was analyzed using *** We identified 1898 proteins from Urimem samples using label-free proteome quantification,of which 56 urine proteins were differentially expressed among the three regions(P<0.05).Hierarchical clustering analysis showed that inter-regional differences caused less significant changes in the urine proteome than intersex *** gender stratification,16 differential proteins were identified in male samples and 84 differential proteins were identified in female *** these differential proteins,several proteins have been previously reported as urinary disease *** Urimem will facilitate urinary protein storage for large-scale urine sample *** differences are a confounding factor influencing the urine proteome and should be considered in future multicenter biomarker studies.
目的建立阵列式标签标记的高通量测序方法并结合多克隆预筛选实现对点突变单克隆细胞株的高效鉴定。方法通过CRISPR/Cas9介导的同源重组修复(HDR)在K562细胞的rs826415位点引入G到T点突变。侯选细胞按每孔10~20个的密度接种培养多克隆,以带有标签(barcode)的引物区分各多克隆细胞,PCR扩增含rs826415位点的区段,产物合并进行二代测序。生物信息学分析各多克隆细胞的同源重组率及插入/缺失率。将阳性率最高孔内的细胞进一步单克隆培养并鉴定基因型。结果通过CRISPR/Cas9同源重组法和有限稀释获得96个rs826415位点打靶的多克隆细胞。经阵列式标签高通量测序法分析各孔细胞同源重组且不伴随插入/缺失(HDR without indel)的比率,96个多克隆的平均阳性率为0.21%,最高达4.35%,将该多克隆细胞进一步单克隆培养,从30个单克隆中成功获得rs826415位点由G/G突变为T/G的杂合型细胞株。结论通过阵列式标签高通量测序策略结合多克隆细胞预筛选,实现了定点突变单克隆细胞株的高效鉴定,相比常规方法显著降低了工作量和成本。
暂无评论